Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2003;108:305-312
Published online before print June 30, 2003, doi: 10.1161/01.CIR.0000079174.13444.9C
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
108/3/305    most recent
01.CIR.0000079174.13444.9Cv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Salles, G.
Right arrow Articles by Cardoso, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Salles, G.
Right arrow Articles by Cardoso, C.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Cardiomyopathy
*Chagas Disease
Related Collections
Right arrow Myocardial cardiomyopathy disease
Right arrow Electrocardiology
Right arrow Arrhythmias, clinical electrophysiology, drugs

(Circulation. 2003;108:305.)
© 2003 American Heart Association, Inc.


Clinical Investigation and Reports

Prognostic Value of QT Interval Parameters for Mortality Risk Stratification in Chagas’ Disease

Results of a Long-Term Follow-Up Study

Gil Salles, MD; Sergio Xavier, MD, PhD; Andrea Sousa, MD; Alejandro Hasslocher-Moreno, MD; Claudia Cardoso, MD, PhD

From the Department of Internal Medicine (G.S., S.X., A.S., C.C.), Clementino Fraga Filho University Hospital, Federal University of Rio de Janeiro, and the Evandro Chagas Hospital (S.X., A.S., A.H.-M.), Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.

Correspondence to Gil Salles, MD, Rua Cróton 72, Jacarepagua, Rio de Janeiro, Brazil, CEP 22750-240. E-mail gilsalles{at}hucff.ufrj.br

Received September 9, 2002; de novo received February 24, 2003; revision received April 24, 2003; accepted April 25, 2003.

Background— QT interval parameters are potential prognostic markers of arrhythmogenicity risk and cardiovascular mortality and have never been evaluated in Chagas’ disease.

Methods and Results— Outpatients (738) in the chronic phase of Chagas’ disease were enrolled in a long-term follow-up study. Maximal heart rate-corrected QT (QTc) and T-wave peak-to-end (TpTe) intervals and QRS, QT, JT, QTapex, and TpTe dispersions and variation coefficients were measured manually and calculated from 12-lead ECGs obtained on admission. Clinical, radiological, and 2-dimensional echocardiographic data were also recorded. Primary end points were all-cause, Chagas’ disease-related, and sudden cardiac mortalities. During a follow-up of 58±39 months, 62 patients died, 54 of Chagas’ disease-related causes and 40 suddenly. Multivariate Cox survival analysis revealed that the QT-interval dispersion (QTd) (hazard ratio, 1.45; 95% confidence interval, 1.29 to 1.63; P<0.001, for 10-ms increments) and left ventricular (LV) end-systolic dimension (hazard ratio, 1.36; 95% confidence interval, 1.21 to 1.53; P<0.001, for 5-mm increments) were the strongest independent predictors for all end points. The maximum QTc interval (QTcmax) could substitute for QTd with a worse predictive performance. Other predictors were heart rate, presence of pathological Q waves, frequent premature ventricular contractions (PVCs), and isolated left anterior fascicular block (LAFB) on the ECGs. Kaplan-Meier survival curves demonstrated that a QTd >=65 ms or a QTcmax >=465 ms1/2 discriminated the 2 groups with significantly different prognoses.

Conclusions— Electrocardiographic QTd and echocardiographic LV end-systolic dimension were the most important mortality predictors in patients with Chagas’ disease. Heart rate, the presence on ECG of pathological Q waves, frequent PVCs, and isolated LAFB refined the mortality risk stratification.


Key Words: cardiomyopathy • mortality • death, sudden • electrocardiography • echocardiography




This article has been cited by other articles:


Home page
EuropaceHome page
E. H. Medei, J. H.M. Nascimento, R. C. Pedrosa, L. Barcellos, M. O. Masuda, S. Sicouri, M. V. Elizari, and A. C. Campos de Carvalho
Antibodies with beta-adrenergic activity from chronic chagasic patients modulate the QT interval and M cell action potential duration
Europace, July 1, 2008; 10(7): 868 - 876.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
P. Roddy, J. Goiri, L. Flevaud, P. P. Palma, S. Morote, N. Lima, L. Villa, F. Torrico, and P. Albajar-Vinas
Field Evaluation of a Rapid Immunochromatographic Assay for Detection of Trypanosoma cruzi Infection by Use of Whole Blood
J. Clin. Microbiol., June 1, 2008; 46(6): 2022 - 2027.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
C. Bern, S. P. Montgomery, B. L. Herwaldt, A. Rassi Jr, J. A. Marin-Neto, R. O. Dantas, J. H. Maguire, H. Acquatella, C. Morillo, L. V. Kirchhoff, et al.
Evaluation and Treatment of Chagas Disease in the United States: A Systematic Review
JAMA, November 14, 2007; 298(18): 2171 - 2181.
[Abstract] [Full Text] [PDF]


Home page
Am J Trop Med HygHome page
S. Williams-Blangero, T. Magalhaes, E. Rainwater, J. Blangero, R. Correa-Oliveira, and J. L. VandeBerg
Electrocardiographic Characteristics in a Population with High Rates of Seropositivity for Trypanosoma cruzi Infection
Am J Trop Med Hyg, September 1, 2007; 77(3): 495 - 499.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Rassi Jr, A. Rassi, and S. G. Rassi
Predictors of Mortality in Chronic Chagas Disease: A Systematic Review of Observational Studies
Circulation, March 6, 2007; 115(9): 1101 - 1108.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. Acquatella
Echocardiography in Chagas Heart Disease
Circulation, March 6, 2007; 115(9): 1124 - 1131.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
A. Rassi Jr., A. Rassi, W. C. Little, S. S. Xavier, S. G. Rassi, A. G. Rassi, G. G. Rassi, A. Hasslocher-Moreno, A. S. Sousa, and M. I. Scanavacca
Development and Validation of a Risk Score for Predicting Death in Chagas' Heart Disease
N. Engl. J. Med., August 24, 2006; 355(8): 799 - 808.
[Abstract] [Full Text] [PDF]


Home page
Am J Trop Med HygHome page
L. S. WILSON, A. M. STROSBERG, and K. BARRIO
COST-EFFECTIVENESS OF CHAGAS DISEASE INTERVENTIONS IN LATIN AMERICA AND THE CARIBBEAN: MARKOV MODELS
Am J Trop Med Hyg, November 1, 2005; 73(5): 901 - 910.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
G. Salles, S. Leocadio, K. Bloch, A. R. Nogueira, and E. Muxfeldt
Combined QT Interval and Voltage Criteria Improve Left Ventricular Hypertrophy Detection in Resistant Hypertension
Hypertension, November 1, 2005; 46(5): 1207 - 1212.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
V. Esteban, O. Lorenzo, M. Ruperez, Y. Suzuki, S. Mezzano, J. Blanco, M. Kretzler, T. Sugaya, J. Egido, and M. Ruiz-Ortega
Angiotensin II, via AT1 and AT2 Receptors and NF-{kappa}B Pathway, Regulates the Inflammatory Response in Unilateral Ureteral Obstruction
J. Am. Soc. Nephrol., June 1, 2004; 15(6): 1514 - 1529.
[Abstract] [Full Text] [PDF]